Medical devices and diagnostics
Digital Health Strategy for Medical Device Companies
Use connected-care market intelligence to decide which digital capabilities, partners, and markets can extend the value of a device or diagnostics portfolio.
Map how software, AI, data, and care pathways are reshaping relevant device and diagnostics categories.
Assess technical fit, evidence, maturity, interoperability, and commercial readiness across potential partners.
Prioritise build, buy, partner, and market-entry choices against strategic value and execution risk.
The decision context
Connected care changes the value proposition around the device
Medical device companies increasingly compete through the workflow, data, and services around the product. Remote monitoring, AI, software, diagnostics, and care-navigation capabilities can extend value, but they also introduce unfamiliar evidence, integration, regulatory, and partnership risks.
Galen Growth gives MedTech teams a structured view of connected-care markets, relevant ventures, competitive moves, clinical evidence, and adoption signals so product and partnership decisions are based on comparable intelligence.
What Galen Growth evaluates
Support across the MedTech innovation lifecycle
Each engagement starts with the decision, then brings together the market, company, clinical, partnership, and execution evidence required to answer it.
Connected-care market mapping
Define the product-adjacent digital ecosystem, care pathways, category maturity, and emerging whitespace.
Explore capability →02Digital health partnerships
Identify and evaluate ventures against product strategy, technical fit, clinical evidence, and implementation readiness.
Explore capability →03MedTech competitive intelligence
Track connected-product portfolios, partnerships, investment activity, and emerging competitor positions.
Explore capability →04Market access intelligence
Understand stakeholder dynamics, evidence expectations, reimbursement signals, and adoption pathways.
Explore capability →05Portfolio evaluation
Compare product and partnership exposure to reveal evidence gaps, concentration risk, duplication, and strategic fit.
Explore capability →06Market expansion
Prioritise markets, care settings, customer segments, and routes to adoption using comparable evidence.
Explore capability →Powered by HealthTech Alpha
Medical device innovation intelligence grounded in observable activity
HealthTech Alpha provides structured, point-in-time intelligence across ventures, products, partnerships, funding, evidence, and market activity. It gives medical device teams a governed evidence base for repeatable analysis rather than disconnected searches.
Explore HealthTech Alpha- Connected-care category benchmarks
- Clinical and regulatory signals
- Partner maturity and fit
- Competitor portfolio activity
Methodology
From strategic question to accountable action
- Define the product decision
Clarify the workflow, customer, evidence, technical, and commercial outcomes required.
- Map the connected ecosystem
Structure relevant categories, competitors, capabilities, ventures, and market conditions.
- Evaluate the alternatives
Compare build, partner, acquisition, and market options against consistent criteria.
- Set the roadmap
Translate the evidence into priorities, decision gates, partner actions, and market sequencing.
Relevant work
How Galen Growth has supported related decisions
Selecting Cardiac Remote Monitoring Partners for Personalised Patient Care
Enabled BD and franchise teams to move decisively to partnership evaluation with a defensible top-10 list.
Read case study →Case studySelecting Personal Health Ventures for Two Priority Therapeutic Areas
Enabled BD and franchise teams to enter partnership conversations with a defensible top-10.
Read case study →Case studyShortlisting personal health ventures in key therapeutic areas
A global leading medical device company sought to understand the personal health Digital Health landscape for two priority therapeutic areas in key global ecosystems to identify and evaluate relevant ventures
Read case study →Related intelligence
Research for this decision context
Explore Galen Growth analysis and reports built from the same digital health evidence base.
FAQ
Common questions
What is digital health strategy for medical device companies?
It is the process of deciding how software, data, AI, digital services, and partnerships should strengthen a device portfolio, clinical workflow, evidence base, and commercial model.
Can Galen Growth support partner scouting for connected care?
Yes. We identify and compare partners by use case, technical fit, evidence, maturity, market presence, and ability to integrate into the intended workflow.
Does the analysis cover market access?
Yes. It can include buyer and stakeholder dynamics, evidence expectations, reimbursement signals, local partners, and adoption pathways.
Who we help